Steven Cohen’s Ovid Therapeutics OVID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.35M Buy
2,549,273
+603,546
+31% +$1.58M 0.01% 1653
2026
Q2
$5.23M Buy
1,945,727
+625,117
+47% +$1.61M 0.01% 1724
2026
Q1
$2.93M Sell
1,320,610
-2,230,519
-63% -$3.99M ﹤0.01% 2059
2025
Q4
$5.79M Buy
+3,551,129
New +$5.47M 0.01% 1730

Other funds holding OVID

Steven Cohen's OVID Position: Q3 2026 in Review

Steven Cohen increased its Ovid Therapeutics (OVID) stake by 31% in Q3 2026, buying an estimated $1.58M and bringing the position to 2,549,273 shares worth $6.35M. The position accounts for 0.01% of the portfolio, ranked #1653.

Steven Cohen first reported a position in OVID in Q4 2025 and has held it in 4 quarters since. 127 funds tracked by Wall St. Rank hold OVID as of Q3 2026.

  • Steven Cohen held 2,549,273 shares of Ovid Therapeutics worth $6.35M as of Q3 2026.
  • Steven Cohen bought 603,546 Ovid Therapeutics shares in Q3 2026, an estimated $1.58M.
  • Ovid Therapeutics made up 0.01% of Steven Cohen's portfolio in Q3 2026, its #1653 holding.
  • Steven Cohen first reported a position in Ovid Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • 127 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.